Prescription Drug Monitoring Program

The Oregon Prescription Drug Monitoring Program (PDMP) is a tool to help healthcare providers and pharmacists provide patients better care in managing their prescriptions. It contains information provided by Oregon-licensed retail pharmacies.

Pharmacies submit prescription data to the PDMP system for all Schedules II, III and IV controlled substances, gabapentin, and naloxone dispensed from Oregon pharmacies and to Oregon residents from non-resident pharmacies. The protected health information is collected and stored securely.

Oregon-licensed healthcare providers and pharmacists and their staff may be authorized for an account to access information from the PDMP system. Bordering state licensed healthcare providers may also be authorized for access accounts. By law their access is limited to patients under their care.

The program was started to support the appropriate use of prescription drugs. The information is intended to help people work with their healthcare providers and pharmacists to determine what medications are best for them.

Upcoming

Notice of Proposed Rulemaking

House Bill 3258 (Oregon Laws 2023, chapter 438) was passed by the 2023 Oregon Legislature and made minor alterations to the Prescription Drug Monitoring Program (PDMP) statute. Two changes that must be reflected in rule:

• Add schedule V drugs and fields related to veterinarian prescribed drugs to be reported to the PDMP. The PDMP currently collects schedule II-IV drugs, however, schedule V drugs have also been shown to carry risk for abuse and overdose, especially when combined with other medications. Collecting these drugs in the PDMP will improve providers’ knowledge of the patient’s comprehensive prescription history prior to prescribing. Similarly, collecting veterinarian prescribed drugs and new fields to properly categorize them within the PDMP will improve providers’ knowledge of additional risk factors facing their patients.
• Add the director of the division of the Oregon Health Authority responsible for the state medical assistance program to be allowed to submit requests for information from the program. This is similar to other oversight roles (coordinated care organization (CCO) directors, medical directors) that are allowed to submit requests for data to oversee their entities.

Notice to Interested Parties

You are invited to review and comment on the proposed rules.

Written comments may be submitted before 5:00 P.M. Pacific Time on December 23, 2024:

• Email comments to: publichealth.rules@odhsoha.oregon.gov
• Mail comments* to:
• OHA, Public Health Division
• Brittany Hall, Administrative Rules Coordinator
• 800 NE Oregon St. Suite 930 Portland, OR 97232
• * Comments sent by regular mail must be postmarked by 5:00 P.M. Pacific Time on December 23, 2024.
• Send comments by fax to: 971-673-1299

An updated dispensers guide will be distributed to pharmacies to assist in preparation for these changes. Should you have any policy-related questions, please contact the OR PDMP office at Email PDMP Health. If you have questions regarding technical assistance please contact Bamboo Health at 866-205-1222.